StocksFin Logo
BSX logo
$BSX

Boston Scientific Corporation

BSX country of incorporation
|
|
Mr. Michael Mahoney
|
41,000 employees
NYSE | Healthcare | Medical Devices
BSX reported its Q322 earnings on November 3, 2022 (98 weeks ago).
$3.17B 8.1% vs. Q321 Revenues Q322
69.12% 0.4% vs. Q321 Gross Profit Margin
5.49% -61.6% vs. Q321 Net Profit Margin
320M -10.6% vs. Q321 Free Cash Flow Q322
$0.12 -57.1% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
3.17B
-2.3%
979M
174M
-33.1%
$0.12
Q22022
3.24B
+7.2%
1.02B
260M
+136.4%
$0.17
Q12022
3.03B
967M
110M
$0.07
FY2021
11.89B
3.76B
1.04B
$0.73
Q42021
3.13B
+6.7%
983M
95M
-77.3%
$0.06
Q32021
2.93B
-4.7%
914M
419M
+125.3%
$0.28
Q22021
3.08B
+11.8%
957M
186M
-45.5%
$0.12
Q12021
2.75B
906M
341M
$0.23
FY2020
9.91B
3.47B
-82M
$-0.06
FY2019
10.74B
3.12B
4.7B
$3.38
FY2018
9.82B
2.81B
1.67B
$1.21
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
31.95B
14.31B
338M
8.58B
17.64B
Q22022
32.19B
14.94B
276M
8.97B
17.25B
Q12022
32.34B
15.6B
325M
9.68B
16.74B
FY2021
32.23B
15.61B
1.93B
9.71B
16.62B
FY2020
30.78B
15.45B
1.73B
9.14B
15.33B
FY2019
30.57B
16.69B
217M
11.41B
13.88B
FY2018
21B
12.27B
146M
9.28B
8.73B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
470M
-225M
-199M
-150M
320M
+58.4%
Q22022
307M
-29M
-344M
-105M
202M
+212.8%
Q12022
-58M
-1.57B
-6M
-121M
-179M
FY2021
1.87B
-1.6B
-95M
-554M
1.32B
FY2020
1.51B
-411M
293M
-376M
1.13B
FY2019
1.84B
-5.04B
2.97B
-461M
1.38B
FY2018
310M
-1.92B
1.43B
-316M
-6M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees